Form 4 holding
Title: Chief Operating and Development Officer
Neumora Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 48,750
- Estimated value
- $77,751
- Report date
- 21 Aug 2026
- Price
- $1.59
- Ownership
- Direct